MedinCell S.A.
MDCLFOTCHealthcare● Active
$34.39
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$34.39
52W Low$6.9757
MedinCell S.A.（MDCLF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MDCLF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($18.44M) | ($25.04M) | ($32.01M) | ($24.81M) | ($19.02M) |
| Depreciation & Amort. | $1.99M | $1.72M | $1.67M | $1.52M | $1.34M |
| Stock-Based Comp. | $2.96M | $2.81M | $2.28M | $2.39M | $1.56M |
| Change in Working Capital | $24.53M | $3.18M | ($3.04M) | ($2.37M) | $0.62M |
| Net Cash from Operations | $19.46M | ($11.92M) | ($21.00M) | ($21.36M) | ($12.14M) |
| Investing Activities | |||||
| Capital Expenditure | ($1.66M) | ($1.19M) | ($1.03M) | ($1.97M) | ($0.82M) |
| Purchases of Investments | $0.00M | $0.00M | ($0.33M) | ($1.21M) | ($0.28M) |
| Sales of Investments | $0.00M | $0.00M | $2.56M | $1.55M | $0.00M |
| Net Cash from Investing | ($13.21M) | ($0.61M) | $1.30M | ($0.32M) | ($1.06M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | ($0.03M) | $0.00M | ($0.19M) | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($4.11M) | $5.08M | $5.83M | $0.47M | $9.44M |
| Net Cash from Financing | $33.32M | $25.53M | $1.56M | ($0.80M) | $47.92M |
| Free Cash Flow | |||||
| Free Cash Flow | $17.80M | ($13.11M) | ($22.03M) | ($23.34M) | ($12.96M) |
| FCF Margin %(computed) | 69.71% | -143.16% | -221.56% | -570.56% | -158.26% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · EUR · M
深入了解MedinCell S.A.
关于MedinCell S.A.（MDCLF）现金流量表
MedinCell S.A. 2025财年经营活动现金流$0.02B，自由现金流$0.02B（FCF利润率69.71%），资本支出($0.00B)。
常见问题
MDCLF · 4 问MedinCell S.A. 2025财年自由现金流$0.02B，同比up235.8%。
MDCLF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10